Mechanisms of metastasis of tumor cells rely upon cell movement and protrusive activity. Thus a molecular understanding of amoeboid chemotaxis in metastatic cancer cells may identify new targets for therapeutic intervention. The rat mammary adenocarcinoma cell line MTLn3 provides a number of advantages for such studies. These cells grow easily in tissue culture and, when injected into the mammary fat pad of syngeneic Fisher 344 rats, form first a primary tumor and then lymph node and lung metastases. MTLn3 cells express roughly 50,000 EGF receptors per cell, while a nonmetastatic derivative termed MTC from the same original tumor does not express EGF receptors. Expression of the EGF receptor in the MTC cells increases metastatic ability without affecting primary tumor growth rate. This result combined with the literature correlating expression of EGF receptor family members with poor prognosis for cancer patients highlights the potential usefulness of analyzing chemotactic responses to EGF.